We are live on ! Find out more
ALT icon

Altimmune
ALT

128 hedge funds and large institutions have $1.03B invested in Altimmune in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

719% more call options, than puts

Call options by funds: $60M | Put options by funds: $7.33M

61% more capital invested

Capital invested by funds: $640M → $1.03B (+$391M)

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

5% more funds holding

Funds holding: 122 → 128 (+6)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

7.09% less ownership

Funds ownership: 102.32% → 95.24% (-7.1%)

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.06%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
36
Increased
38
Reduced
35
Closed
30
Calls
$60M
Puts
$7.33M
Net Calls
+$52.7M
Net Calls Change
+$22.7M

Top Buyers

1
State Street
State Street
Massachusetts
+$28.3M
2
APM
Avidity Partners Management
Texas
+$14.7M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$12.1M
4
Citadel Advisors
Citadel Advisors
Florida
+$11.6M
5
Jennison Associates
Jennison Associates
New York
+$8.39M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$49.5M
2
DCM
Driehaus Capital Management
Illinois
-$15.6M
3
BBA
Baker Bros. Advisors
New York
-$12.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.64M
5
LGM
Logos Global Management
California
-$9.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$7.01M +$4.78M +425,849 New
UBS Group
27
UBS Group
Switzerland
$6.3M +$3.67M +326,792 +581%
SFM
28
Sphera Funds Management
Israel
$6.26M -$2.47M -220,000 -37%
Barclays
29
Barclays
United Kingdom
$5.94M +$1.95M +173,277 +92%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$5.79M +$1.99M +176,786 +101%
SAM
31
Sectoral Asset Management
Quebec, Canada
$5.63M +$824K +73,400 +27%
TLP
32
Tri Locum Partners
New York
$5.36M +$1.89M +168,391 +107%
Citigroup
33
Citigroup
New York
$4.8M +$221K +19,699 +7%
IC
34
Ikarian Capital
Texas
$4.5M -$2.23M -198,622 -42%
Jane Street
35
Jane Street
New York
$4.03M +$164K +14,580 +6%
BWCS
36
Beirne Wealth Consulting Services
Connecticut
$3.9M -$514K -45,800 -16%
Simplex Trading
37
Simplex Trading
Illinois
$3.73M +$998K +88,886 +65%
RSCM
38
Rock Springs Capital Management
Maryland
$3.67M – – –
Macquarie Group
39
Macquarie Group
Australia
$3.43M +$2.34M +208,685 New
CS
40
Candriam SCA
Luxembourg
$3.29M – – –
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$2.96M -$9.64M -857,914 -83%
JP Morgan Chase
42
JP Morgan Chase
New York
$2.95M -$5.3M -471,930 -72%
Group One Trading
43
Group One Trading
Illinois
$2.89M +$1.54M +137,151 +355%
KCM
44
Knoll Capital Management
Florida
$2.86M – – –
Millennium Management
45
Millennium Management
New York
$2.38M -$4.05M -360,989 -71%
Northern Trust
46
Northern Trust
Illinois
$2.3M +$320K +28,529 +26%
EMG
47
ETF Managers Group
New Jersey
$2.27M +$1.39M +123,729 +855%
PIM
48
Platinum Investment Management
Australia
$1.95M – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.95M +$1.33M +118,300 New
Prudential Financial
50
Prudential Financial
New Jersey
$1.82M +$1.24M +110,650 New
1
2
3 4 5

ALT Hedge Fund Activity: Q4 2022 in Review

128 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2022, worth a combined $1.03B — up 61% from $640M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ALT positions and 30 closed out — a net gain of 6 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was State Street, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $49.5M.

  • 128 institutional investors held Altimmune (ALT) as of Q4 2022, up from 122 in Q3 2022.
  • Funds reported $1.03B of Altimmune stock for Q4 2022, up 61% quarter-over-quarter.
  • 36 funds opened new Altimmune positions in Q4 2022 and 30 closed out, a net change of +6 holders.
  • The largest Altimmune buyer in Q4 2022 was State Street, an estimated $28.3M added.
  • The largest Altimmune seller in Q4 2022 was Janus Henderson Group, an estimated $49.5M sold.

Based on aggregated 13F filings for Q4 2022.